NO20032902D0 - Medisinske preparater som inneholder aspirin - Google Patents

Medisinske preparater som inneholder aspirin

Info

Publication number
NO20032902D0
NO20032902D0 NO20032902A NO20032902A NO20032902D0 NO 20032902 D0 NO20032902 D0 NO 20032902D0 NO 20032902 A NO20032902 A NO 20032902A NO 20032902 A NO20032902 A NO 20032902A NO 20032902 D0 NO20032902 D0 NO 20032902D0
Authority
NO
Norway
Prior art keywords
pharmaceutical compositions
aspirin
containing aspirin
medications containing
äeffectü
Prior art date
Application number
NO20032902A
Other languages
English (en)
Norwegian (no)
Other versions
NO20032902L (no
Inventor
Fumitoshi Asai
Atsuhiro Sugidachi
Taketoshi Ogawa
Teruhiko Inoue
Original Assignee
Ube Industries
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=18858878&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20032902(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ube Industries filed Critical Ube Industries
Publication of NO20032902L publication Critical patent/NO20032902L/no
Publication of NO20032902D0 publication Critical patent/NO20032902D0/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4365—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system having sulfur as a ring hetero atom, e.g. ticlopidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/612—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid
    • A61K31/616—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid by carboxylic acids, e.g. acetylsalicylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
NO20032902A 2000-12-25 2003-06-24 Medisinske preparater som inneholder aspirin NO20032902D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2000392983 2000-12-25
PCT/JP2001/011201 WO2002051412A1 (fr) 2000-12-25 2001-12-20 Compositions medicales contenant de l'aspirine

Publications (2)

Publication Number Publication Date
NO20032902L NO20032902L (no) 2003-06-24
NO20032902D0 true NO20032902D0 (no) 2003-06-24

Family

ID=18858878

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20032902A NO20032902D0 (no) 2000-12-25 2003-06-24 Medisinske preparater som inneholder aspirin

Country Status (25)

Country Link
US (3) US20040024013A1 (cs)
EP (1) EP1350511B1 (cs)
KR (1) KR100692934B1 (cs)
CN (1) CN100341506C (cs)
AT (1) ATE407675T1 (cs)
AU (1) AU2002217464B2 (cs)
BR (1) BR0116531A (cs)
CA (1) CA2432644C (cs)
CY (1) CY1108626T1 (cs)
CZ (1) CZ297570B6 (cs)
DE (1) DE60135780D1 (cs)
DK (1) DK1350511T3 (cs)
ES (1) ES2311498T3 (cs)
HU (1) HUP0400644A3 (cs)
IL (2) IL156456A0 (cs)
MX (1) MXPA03005770A (cs)
NO (1) NO20032902D0 (cs)
NZ (1) NZ526540A (cs)
PL (1) PL206138B1 (cs)
PT (1) PT1350511E (cs)
RU (1) RU2262933C2 (cs)
SK (1) SK287972B6 (cs)
TW (1) TWI293249B (cs)
WO (1) WO2002051412A1 (cs)
ZA (1) ZA200304878B (cs)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20130118395A (ko) * 2000-07-06 2013-10-29 다이이찌 산쿄 가부시키가이샤 히드로피리딘 유도체 산부가염
ES2311498T3 (es) 2000-12-25 2009-02-16 Daiichi Sankyo Company, Limited Composiciones medicinales que contienen aspirina.
US20060217351A1 (en) * 2003-05-05 2006-09-28 Brandt John T Method for treating cardiovascular diseases
CN100488163C (zh) * 2005-01-19 2009-05-13 华为技术有限公司 组播业务处理方法和系统
CA2612315A1 (en) * 2005-06-17 2006-12-28 Eli Lilly And Company Dosage regimen for prasugrel
DE102005029612A1 (de) * 2005-06-23 2007-01-04 Hochschule Bremen Vorrichtung zum Erzeugen eines Panoramabildes
US20080214599A1 (en) * 2005-08-19 2008-09-04 John Thomas Brandt Use of Par-1/Par-4 Inhibitors for Treating or Preventing Vascular Diseases
SI2032521T1 (sl) * 2006-06-27 2010-02-26 Sandoz Ag Nov postopek za pripravo soli
JPWO2008072532A1 (ja) * 2006-12-07 2010-03-25 第一三共株式会社 貯蔵安定性が改善された医薬組成物
TWI428151B (zh) * 2006-12-07 2014-03-01 Daiichi Sankyo Co Ltd 含有甘露醇或乳糖之固形製劑
BRPI0719395C1 (pt) * 2006-12-07 2021-05-25 Daiichi Sankyo Co Ltd tablete revestido de filme
TWI482641B (zh) * 2006-12-07 2015-05-01 Daiichi Sankyo Co Ltd 含有低取代度羥丙基纖維素之醫藥組成物
CN101594864B (zh) * 2006-12-07 2012-04-18 第一三共株式会社 生产固体制剂的方法
RU2435776C2 (ru) * 2007-03-02 2011-12-10 Дайити Санкио Компани, Лимитед Способ получения высокочистого празугрель гидрохлорида
NZ581362A (en) 2007-04-27 2011-07-29 Cydex Pharmaceuticals Inc Formulations containing clopidogrel and sulfoalkyl ether cyclodextrin and methods of use
CN101177430A (zh) * 2007-12-11 2008-05-14 鲁南制药集团股份有限公司 氢化吡啶衍生物及其盐的制备方法
US20090281136A1 (en) * 2008-05-08 2009-11-12 Sandeep Mhetre Prasugrel pharmaceutical formulations
KR20110045034A (ko) 2008-08-02 2011-05-03 루난 파마슈티컬 그룹 코퍼레이션 프라수그렐 황산수소염 및 이의 약제학적 조성물 및 용도
ES2769949T3 (es) 2009-05-13 2020-06-29 Cydex Pharmaceuticals Inc Composiciones farmacéuticas que comprenden prasugrel y derivados de ciclodextrina y métodos de preparación y uso de las mismas
CN102228691A (zh) * 2011-06-29 2011-11-02 北京阜康仁生物制药科技有限公司 阿司匹林和一种抗血小板药物的药物组合物
US9757395B2 (en) * 2012-12-20 2017-09-12 Otitopic Inc. Dry powder inhaler and methods of use
US9757529B2 (en) 2012-12-20 2017-09-12 Otitopic Inc. Dry powder inhaler and methods of use
EP3607941A1 (en) 2013-04-30 2020-02-12 Otitopic Inc. Dry powder formulations and methods of use
JP6701086B2 (ja) 2014-02-20 2020-05-27 オティトピック インコーポレイテッド 吸入用の乾燥粉末製剤
WO2016122421A1 (en) 2015-01-29 2016-08-04 Pharmactive Ilaç Sanayi Ve Ticaret A.Ş. Stable pharmaceutical compositions containing prasugrel base

Family Cites Families (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2890240A (en) * 1956-03-28 1959-06-09 Monsanto Chemicals Aspirin crystallisation
US3235583A (en) * 1964-07-22 1966-02-15 Norwich Pharma Co Preparation of aspirin
US3890240A (en) * 1966-11-28 1975-06-17 Pitney Bowes Inc Toner compositions and methods for their preparation
FR2345150A2 (fr) 1975-08-06 1977-10-21 Centre Etd Ind Pharma Nouveaux derives de la thienopyridine, et leur application
FR2215948B1 (cs) 1973-02-01 1976-05-14 Centre Etd Ind Pharma
FR2307538A1 (fr) * 1975-04-18 1976-11-12 Centre Etd Ind Pharma Nouveau medicament anti-agregant plaquettaire
FR2312247A1 (fr) 1975-05-30 1976-12-24 Parcor Derives de la thieno-pyridine, leur procede de preparation et leurs applications
FR2358150A1 (fr) * 1976-07-13 1978-02-10 Parcor Nouvelles thieno (2,3-c) et (3,2-c) pyridines, leur procede de preparation et leur application
FR2376860A1 (fr) * 1977-01-07 1978-08-04 Parcor Tetrahydro-4,5,6,7 thieno (2,3-c) et (3,2-c) pyridines, leur procede de preparation et leur application therapeutique
GB1576511A (en) * 1977-03-29 1980-10-08 Parcor Thieno(2,3 - c) and (3,2 - c) pyridines process for their preparation and therapeutic applications thereof
GB2038625B (en) * 1978-12-29 1983-01-12 Parcor Therapeutic composition having an antithrombotic and antiblood-platelet-aggregating activity
CA1147658A (en) 1980-01-03 1983-06-07 Edouard Panak Therapeutic compositions having antithrombotic and anti-blood-platelet- aggregating activity
US4400384A (en) * 1980-10-06 1983-08-23 Sanofi, S.A. 5-o-Cyanobenzyl-4,5,6,7-tetrahydrothieno [3,2-c] pyridine methanesulfonate and other novel salts thereof
US4321266A (en) * 1980-10-06 1982-03-23 Sanofi 5-o-Cyanobenzyl-4,5,6,7-tetrahydrothieno [3,2-C] pyridine
FR2495156A1 (fr) * 1980-11-28 1982-06-04 Sanofi Sa Derives de la thieno-pyridinone, leur procede de preparation et leur application therapeutique
FR2528848A1 (fr) * 1982-06-16 1983-12-23 Sanofi Sa Nouveau derive de thieno-pyridone, son procede de preparation et son application therapeutique
FR2530247B1 (fr) * 1982-07-13 1986-05-16 Sanofi Sa Nouveaux derives de la thieno (3, 2-c) pyridine, leur procede de preparation et leur application therapeutique
FR2576901B1 (fr) * 1985-01-31 1987-03-20 Sanofi Sa Nouveaux derives de l'acide a-(oxo-2 hexahydro-2,4,5,6,7,7a thieno (3,2-c) pyridyl-5) phenyl acetique, leur procede de preparation et leur application therapeutique
FR2596392B1 (fr) 1986-03-27 1988-08-05 Sanofi Sa Derives de l'acide a-(hydroxy-3 oxo-2 hexahydro-2,4,5,6,7,7a thieno (3,2-c) pyridyl-5) phenylacetique, leur procede de preparation, leur application comme medicaments et les compositions les renfermant
FR2597102B1 (fr) 1986-04-14 1988-08-26 Sanofi Sa Derives de l'acide a-(hydroxy-7 tetrahydro-4,5,6,7 thieno (3,2-c) pyridyl-5) phenyl acetique, leur procede de preparation, leur application comme medicament et les compositions les renfermant
FR2652579B1 (fr) * 1989-10-02 1992-01-24 Sanofi Sa Derives d'hydroxy-2 thiophene et furanne condenses avec un cycle azote, sur procede de preparation et leur application en therapeutique.
US5401730A (en) * 1990-07-06 1995-03-28 The Hope Heart Institute Method for reducing platelet aggregation
FI101150B (fi) * 1991-09-09 1998-04-30 Sankyo Co Menetelmä lääkeaineina käyttökelpoisten tetrahydrotienopyridiinin johd annaisten valmistamiseksi
ZA926784B (en) * 1991-09-09 1993-03-29 Sankyo Co Tetrahydrothienopyridine derivatives, furo and pyrrolo analogs thereof and their preparation and uses for inhibiting blood platelet aggregation.
JP2712144B2 (ja) 1992-02-06 1998-02-10 田辺製薬株式会社 血小板凝集抑制組成物
EP0573975A1 (en) 1992-06-08 1993-12-15 Fuji Photo Film Co., Ltd. 2-alkoxycarbonyl-5-o-chlorobenzyl-4,5,6,7-tetrahydrothieno[3,2-c]pyridine derivative and process for producing the same
ATE166047T1 (de) 1993-03-17 1998-05-15 Meiji Seika Co Neue verbindungen mit blutplättchenaggregationshemmender aktivität
JPH06271582A (ja) 1993-03-18 1994-09-27 Fuji Photo Film Co Ltd ４，５，６，７−テトラヒドロチエノ〔３，２−ｃ〕ピリジン誘導体の製造方法
WO1996011203A1 (fr) * 1994-10-07 1996-04-18 Ube Industries, Ltd. 2-silyloxytetrahydrothienopyridine, son sel, et son procede de production
JP3564791B2 (ja) 1995-04-21 2004-09-15 宇部興産株式会社 α−アミノケトン類の製造方法
FR2744918B1 (fr) 1996-02-19 1998-05-07 Sanofi Sa Nouvelles associations de principes actifs contenant un derive de thieno(3,2-c)pyridine et un antithrombotique
ES2246575T3 (es) * 1998-06-17 2006-02-16 Bristol-Myers Squibb Company Prevencion del infarto cerebral mediante la administracion de una combinacion de un farmaco antiplaquetario bloqueador del receptor adp y un farmaco antihipertensivo.
US6509348B1 (en) * 1998-11-03 2003-01-21 Bristol-Myers Squibb Company Combination of an ADP-receptor blocking antiplatelet drug and a thromboxane A2 receptor antagonist and a method for inhibiting thrombus formation employing such combination
IT1306980B1 (it) 1999-01-13 2001-10-11 Magneti Marelli Spa Gruppo motore-cambio di velocita', in particolare per motocicli.
CN1108798C (zh) * 1999-01-26 2003-05-21 广东药学院 一种治疗、预防血栓形成及中风的复方制剂及其制备方法
JP2000266780A (ja) 1999-03-18 2000-09-29 Matsushita Electric Ind Co Ltd プローブカードとそれを用いた検査装置
IT1311924B1 (it) 1999-04-13 2002-03-20 Nicox Sa Composti farmaceutici.
IT1311923B1 (it) 1999-04-13 2002-03-20 Nicox Sa Composti farmaceutici.
FR2792836B3 (fr) 1999-04-30 2001-07-27 Sanofi Sa Composition pharmaceutique sous forme unitaire contenant de l'aspirine et de l'hydrogenosulfate de clopidogrel
MY125533A (en) * 1999-12-06 2006-08-30 Bristol Myers Squibb Co Heterocyclic dihydropyrimidine compounds
JP4001199B2 (ja) 2000-07-06 2007-10-31 第一三共株式会社 ヒドロピリジン誘導体酸付加塩
KR20130118395A (ko) * 2000-07-06 2013-10-29 다이이찌 산쿄 가부시키가이샤 히드로피리딘 유도체 산부가염
HUP0400651A2 (hu) * 2000-11-07 2004-06-28 Bristol-Myers Squibb Company Szerin proteáz inhibitorokként alkalmazható savszármazékok és ezeket tartalmazó gyógyszerkészítmények
ES2311498T3 (es) 2000-12-25 2009-02-16 Daiichi Sankyo Company, Limited Composiciones medicinales que contienen aspirina.
US6670386B2 (en) * 2001-07-31 2003-12-30 Bristol-Myers Squibb Company Bicyclic modulators of androgen receptor function
DE10305984A1 (de) * 2003-02-13 2004-09-02 Helm Ag Salze organischer Säuren mit Clopidogrel und deren Verwendung zur Herstellung phamazeutischer Formulierungen
US20060154957A1 (en) * 2004-09-21 2006-07-13 Nina Finkelstein Crystalline clopidogrel hydrobromide and processes for preparation thereof
US20110003847A1 (en) * 2008-02-06 2011-01-06 Helm Ag Prasugrel Salts with Improved Properties
DE202008003557U1 (de) 2008-03-13 2008-06-05 Riela - Getreidetechnik Karl-Heinz Knoop E.K. Schubwendetrockner mit Feuchte-Messeinrichtung
PL2112155T3 (pl) 2008-04-25 2011-03-31 Sandoz Ag Wodorosiarczan (VI) 2-acetoksy-5-(α-cyklopropylokarbonylo-2-fluorobenzylo)-4,5,6,7-tetrahydrotieno[3,2-c]pirydyny i sposób jego otrzymywania
GB2469883A (en) 2009-04-30 2010-11-03 Sandoz Ag Novel crystalline form of Prasugrel hydrogensulphate
HU3745U (en) 2009-10-01 2010-03-29 Laszlo Borzan Disk guide device for target disk launcher or bowler equipments

Also Published As

Publication number Publication date
SK287972B6 (sk) 2012-08-06
PT1350511E (pt) 2008-10-28
PL206138B1 (pl) 2010-07-30
BR0116531A (pt) 2004-02-25
HUP0400644A2 (hu) 2004-06-28
HUP0400644A3 (en) 2009-06-29
NO20032902L (no) 2003-06-24
CZ20031660A3 (cs) 2003-12-17
IL156456A (en) 2006-12-10
US8404703B2 (en) 2013-03-26
KR20030065558A (ko) 2003-08-06
ES2311498T3 (es) 2009-02-16
TWI293249B (en) 2008-02-11
KR100692934B1 (ko) 2007-03-12
CY1108626T1 (el) 2014-04-09
EP1350511A4 (en) 2004-06-23
CA2432644C (en) 2013-07-23
ATE407675T1 (de) 2008-09-15
NZ526540A (en) 2004-11-26
PL363183A1 (en) 2004-11-15
CZ297570B6 (cs) 2007-02-07
ZA200304878B (en) 2004-08-10
IL156456A0 (en) 2004-01-04
US8569325B2 (en) 2013-10-29
CN1491109A (zh) 2004-04-21
AU2002217464B2 (en) 2004-12-16
SK7542003A3 (en) 2003-12-02
US20080108589A1 (en) 2008-05-08
MXPA03005770A (es) 2003-09-10
CA2432644A1 (en) 2002-07-04
DK1350511T3 (da) 2009-01-05
US20070010499A1 (en) 2007-01-11
DE60135780D1 (de) 2008-10-23
EP1350511B1 (en) 2008-09-10
CN100341506C (zh) 2007-10-10
HK1056118A1 (en) 2004-02-06
WO2002051412A1 (fr) 2002-07-04
RU2262933C2 (ru) 2005-10-27
US20040024013A1 (en) 2004-02-05
EP1350511A1 (en) 2003-10-08

Similar Documents

Publication Publication Date Title
NO20032902D0 (no) Medisinske preparater som inneholder aspirin
NO2025027I1 (no) Pharmaceutical mixture or association that includes as active ingredients: (1) ceftazidime or a salt thereof, and (2) avibactam or a pharmaceutically acceptable salt thereof - forlenget.
NO20032233L (no) Synergistiske foreninger som innbefatter en renininhibitor for kardiovaskulaere sykdommer
DK0816376T3 (da) Thrombininhibitorer som antikoagulante midler
NO20034612L (no) 3,4-di-substituerte syklobuten-1,2-dioner, farmasoytiske preparater som omfatter forbindelsene, samt anvendelse av forbindelsene for tilvirkning av medikamenter for behandling av kjemokinformidlede sykdommer
NO20034149L (no) Legemidler inneholdende triazaspiro[5.5]undekanderivater som den aktive bestanddel
CA2183972A1 (en) Oxazolidinone derivatives and pharmaceutical compositions containing them
EP1734041A3 (en) Platelet ADP receptor inhibitors
WO2003037860A3 (en) Purine analogs having hsp90-inhibiting activity
EP1303271A4 (en) Ophthalmic formulation of a selective cyclooxygenase-2 inhibitory drug
NO950297D0 (no) Prolinamidderivater
CA2481848A1 (en) Active ingredient particles carrying clopidogrel or a salt thereof, their use and method of preparation
NO20042739L (no) Farmasoytiske sammensetninger av 5,6,14-triazatetracyklo(10.3.1.0(2,11).0(4,9))-heksadeca-2(11)3,5,7,9-pentan
WO2001087329A8 (en) Liquid pharmaceutical composition containing an erythropoietin derivate
CY1110395T1 (el) Αλατα προσθηκης οξεος παραγωγων υδροπυριδινης
HUP9901144A2 (hu) Hatóanyagként klopidogrel és egy antitrombotikum új kombinációját tartalmazó gyógyszerkészítmények
DK0920421T3 (da) Isoxazolinderivater anvendelige som antimikrobielle midler
ATE395071T1 (de) Pharmazeutische zubereitungen zur angiogenese- therapie
DK0669912T3 (da) N-(3-Piperidinylcarbonyl)-beta-alaninderivater som PAF-antagonister
WO2001081316A3 (en) Substituted phenyl farnesyltransferase inhibitors
DE60029242D1 (de) Arzneien zur begleitenden behandlung von glaukomen
CA2489140A1 (en) Dosage form containing pantoprazole as active ingredient
DE69819539D1 (de) Antithrombotische mittel
SE0002729D0 (sv) Novel compound form
EP1065200A4 (en) Aminoisoquinoline DERIVATIVES

Legal Events

Date Code Title Description
BDEC Board of appeal decision

Free format text: KLAGEN FORKASTES. KLAGENEMNDAS AVGJOERELSE ETTER KLAGE PA INNSIGELSESAVGJOERELSE

Filing date: 20160412

Effective date: 20170206